Ranbaxy Launches Once-a-day Inhaler For Asthma Patients

by Medindia Content Team on  March 25, 2006 at 1:03 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
Indian pharmaceutical major Ranbaxy Laboratories Limited Friday announced the launch of a branded once-a-day inhaler for asthma patients.

"Ranbaxy has introduced this product for the first time in India. Osonide is available in HFA (Hydroxy fluoro Alkane: the propellant) based pressurised metered dose inhalers in two strengths - Osonide 160mcg and Osonide 80mcg," the company said in a statement.

Osonide HFA Inhaler, as opposed to the conventional CFC (chloro-fluoro carbon propellant) inhaler, ensures better delivery in patients' airways with the property of being activated only in the lungs, thereby reducing side effects.

"The product will provide physicians with a contemporary therapeutic option for superior management of asthma therapy," said Sanjeev I. Dani, Ranbaxy's regional director for India and Middle East.

India has an estimated 15-20 million asthmatic patients and the estimated prevalence rate in children aged between five and 11 years is between 10 and 15 percent.

--Edited IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Childhood Asthma Asthma Remedies for Seasonal Allergy Relief Allergy - Symptom Evaluation Wheezing Churg-Strauss Syndrome Tests for Asthma Stay Well This Winter 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...